Key facts
- This page summarizes William Geist Power's Form 4 filing for BIO-TECHNE Corp (TECH).
- 3 reported transactions and 12 derivative rows are listed below.
- Accepted by SEC: 04 Feb 2025, 17:27.
William Geist Power - 01 Feb 2025 Form 4 Insider Report for BIO-TECHNE Corp (TECH)
- Reporting relationship
- PRESIDENT, PROTEIN SCIENCES
- Issuer ticker
- TECH
- Reported as of
- 01 Feb 2025
- Net transaction value
- -$81,567
- SEC form
- 4
- Accepted by SEC
- 04 Feb 2025, 17:27:52 UTC
- Prior SEC filing
- 05 Nov 2024
- Next SEC filing
- 19 Aug 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Andrew Nick as Attorney-in-Fact for William Geist pursuant to Power of Attorney previously filed
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
William Geist Power filed Form 4 for BIO-TECHNE Corp (TECH) on 04 Feb 2025.
Change
- Previous filing in this sequence was filed on 05 Nov 2024.
- Current net transaction value: -$81,567.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TECH
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +3,320
- Change %
- +30%
- Price
- $0.000000
- Shares after
- 14,401
- Date
- 01 Feb 2025
- Ownership
- Direct
TECH
transaction
Common Stock
Tax liability
- Transaction value
- $81,567
- Shares
- -1,109
- Change %
- -7.7%
- Price
- $73.55
- Shares after
- 13,292
- Date
- 01 Feb 2025
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TECH
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -3,320
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 01 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,320
- Exercise price
- Footnotes
- F1, F2
TECH
holding
Derivative
Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 15,912
- Date
- 01 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,912
- Exercise price
- $100.39
- Footnotes
- F3
TECH
holding
Derivative
Performance Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,140
- Date
- 01 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,140
- Exercise price
- Footnotes
- F1, F4
TECH
holding
Derivative
Performance Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 22,200
- Date
- 01 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 22,200
- Exercise price
- $94.52
- Footnotes
- F4
TECH
holding
Derivative
Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 29,600
- Date
- 01 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 29,600
- Exercise price
- $94.52
- Footnotes
- F5
TECH
holding
Derivative
Performance Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 9,074
- Date
- 01 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,074
- Exercise price
- Footnotes
- F1, F6
TECH
holding
Derivative
Performance Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 24,424
- Date
- 01 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 24,424
- Exercise price
- $84.61
- Footnotes
- F6
TECH
holding
Derivative
Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 30,059
- Date
- 01 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 30,059
- Exercise price
- $84.61
- Footnotes
- F7
TECH
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 9,911
- Date
- 01 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,911
- Exercise price
- Footnotes
- F1, F8
TECH
holding
Derivative
Performance Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 15,738
- Date
- 01 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,738
- Exercise price
- Footnotes
- F1, F9
TECH
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,869
- Date
- 01 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,869
- Exercise price
- Footnotes
- F1, F10
TECH
holding
Derivative
Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 21,204
- Date
- 01 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 21,204
- Exercise price
- $74.91
- Footnotes
- F11
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 11 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
Footnote F2
3,320 restricted stock units vest on 2/1/2025.
Footnote F3
Options to purchase 3,980 shares vest on each of 2/1/2023 and 2/1/2025, and options to purchase 3,976 shares vest on each of 2/1/2024 and 2/1/2026.
Footnote F4
Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Footnote F5
Options to purchase 7,400 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.
Footnote F6
Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Footnote F7
Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026.
Footnote F8
9,911 restricted stock units vest on 11/1/2025.
Footnote F9
Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Footnote F10
2,623 restricted stock units vest on each of 8/15/2025, 8/15/2026 and 8/15/2027.
Footnote F11
Options to purchase 5,301 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.